rs374402554
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005257.6(GATA6):c.222G>A(p.Pro74Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000575 in 1,584,364 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00032 ( 4 hom. )
Consequence
GATA6
NM_005257.6 synonymous
NM_005257.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.966
Publications
1 publications found
Genes affected
GATA6 (HGNC:4174): (GATA binding protein 6) This gene is a member of a small family of zinc finger transcription factors that play an important role in the regulation of cellular differentiation and organogenesis during vertebrate development. This gene is expressed during early embryogenesis and localizes to endo- and mesodermally derived cells during later embryogenesis and thereby plays an important role in gut, lung, and heart development. Mutations in this gene are associated with several congenital defects. [provided by RefSeq, Mar 2012]
GATA6 Gene-Disease associations (from GenCC):
- atrial septal defect 9Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics
- atrioventricular septal defect 5Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pancreatic hypoplasia-diabetes-congenital heart disease syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- metabolic syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- neonatal diabetes mellitusInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tetralogy of fallotInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- conotruncal heart malformationsInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 18-22171366-G-A is Benign according to our data. Variant chr18-22171366-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.966 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00298 (453/152202) while in subpopulation AFR AF = 0.0106 (440/41548). AF 95% confidence interval is 0.00977. There are 5 homozygotes in GnomAd4. There are 224 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GATA6 | ENST00000269216.10 | c.222G>A | p.Pro74Pro | synonymous_variant | Exon 2 of 7 | 1 | NM_005257.6 | ENSP00000269216.3 | ||
| GATA6 | ENST00000581694.1 | c.222G>A | p.Pro74Pro | synonymous_variant | Exon 1 of 6 | 1 | ENSP00000462313.1 |
Frequencies
GnomAD3 genomes AF: 0.00296 AC: 450AN: 152090Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
450
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000635 AC: 127AN: 199976 AF XY: 0.000555 show subpopulations
GnomAD2 exomes
AF:
AC:
127
AN:
199976
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000320 AC: 458AN: 1432162Hom.: 4 Cov.: 30 AF XY: 0.000269 AC XY: 191AN XY: 711314 show subpopulations
GnomAD4 exome
AF:
AC:
458
AN:
1432162
Hom.:
Cov.:
30
AF XY:
AC XY:
191
AN XY:
711314
show subpopulations
African (AFR)
AF:
AC:
405
AN:
33066
American (AMR)
AF:
AC:
19
AN:
43144
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25778
East Asian (EAS)
AF:
AC:
1
AN:
38966
South Asian (SAS)
AF:
AC:
1
AN:
84696
European-Finnish (FIN)
AF:
AC:
0
AN:
36732
Middle Eastern (MID)
AF:
AC:
2
AN:
5402
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1104864
Other (OTH)
AF:
AC:
26
AN:
59514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00298 AC: 453AN: 152202Hom.: 5 Cov.: 32 AF XY: 0.00301 AC XY: 224AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
453
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
224
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
440
AN:
41548
American (AMR)
AF:
AC:
9
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5132
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67978
Other (OTH)
AF:
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Jul 28, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Atrioventricular septal defect 5 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.